Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
Neuropsychologist Victoria M. Leavitt, PhD is featured in three EveryDay Health podcasts about recognizing and treating patients with mild cognitive impairment.
A new collaborative study by Drs. Martin Picard and Philip L. De Jager examines the potential link between the brain's mitochondria and a person's psychological stress.
Yaakov Stern, PhD, Florence Irving Professor of Neuropsychology in the Department of Neurology at Columbia University Irving Medical Center talks about his research on cognition and aging.
Jennifer J. Manly, PhD, Professor of Neuropsychology, and Lawrence S. Honig, MD, PhD, Professor of Neurology, comment on donanemab, the second Alzheimer’s drug
Lawrence S. Honig, MD, PhD, a professor of neurology at CUIMC, estimates that group constitutes about a sixth of the more than 6 million Americans currently diagnosed with Alzheimer’s
Stephanie Cosentino, PhD, Associate Professor of Neuropsychology, and colleagues are working on developing screening tools to detect subjective cognitive decline and more advanced forms of memory loss
A new study done by Dr. Jennifer Manly, professor of neuropsychology, and colleagues, found that the quality of the high school you attend may have an impact on cognition later in life
Richard Mayeux, MD, chair of the Department of Neurology at CUMC and colleagues are investigating a set of blood tests that may help correctly diagnose Alzheimer disease in low-resource environments
Many people live years or even decades with dementia, which causes death. Researching the symptoms and causes can dramatically help dementia care and prevention.
As Davangere Devanand, a neurologist at CUIMC, combed through the reams of scientific data on Alzheimer’s, he stumbled across a surprising idea – could an infection be involved in driving the disease?
Of all the possible contributors, intense physical activity was the likely disease-modifying factor, Davangere Devanand, MD, of CUIMC, and co-authors wrote in Alzheimer's & Dementia
"Hispanics and individuals of African ancestry have been significantly underrepresented in research of Alzheimer’s disease, although engaging underserved minorities is critical..." says Dr. Reitz